TURBT

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder CancerNCT04688931URGNPhase 3Terminated2023-03-17Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.